The suits target Novo Nordisk, the Danish manufacturer of Ozempic, Wegovy, Rybelsus, Victoza and Saxenda and Indiana-based Eli Lilly, which makes Trulicity, Mounjaro and Zepbound
Track changes in liver enzymes, liver fat content (via imaging), and other liver health markers
However, insulin pump may not be suitable for every one with type 1 diabetes
These medications can inflame the pancreas further by affecting digestive enzymes and gallbladder function, potentially triggering acute attacks
While the brand name is relatively new, its active ingredient, tirzepatide, has been in use since early 2022
Wegovy has been approved as a weight loss medication in the UK and is available as a once-weekly injection